In Alzheimer’s disease, ApoE was shown to modulate pathology by altering the aggregation and clearance of amyloid-β from the brain, and by modifying neuroinflammation and brain lipid transport10, 11. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.